Beacon Pointe Advisors
BTCY icon

Beacon Pointe Advisors’s Biotricity, Inc. Common Stock BTCY Stock Holding History

Beacon Pointe Advisors’s Portfolio BTCY Stock Details BTCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-5,635
Closed -$77K – 1244
2022
Q1 		$77K Buy
+5,635
New +$97.7K ﹤0.01% 1166

Other funds holding BTCY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
SWMP
Signature Wealth Management Partners Montvale, New Jersey $214M AUM 27.04% 1-Year Est. Return
PWM
PRW Wealth Management Quincy, Massachusetts $262M AUM 22.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Beacon Pointe Advisors's BTCY Position: Q2 2022 in Review

Beacon Pointe Advisors sold out of Biotricity, Inc. Common Stock (BTCY) in Q2 2022, closing a stake of 5,635 shares — an estimated $77K sold.

Beacon Pointe Advisors first reported a position in BTCY in Q1 2022 and held it in 1 quarter. The position peaked at $77K in Q1 2022. 27 funds tracked by Wall St. Rank hold BTCY as of Q2 2022.

  • Beacon Pointe Advisors reported no remaining Biotricity, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Beacon Pointe Advisors sold 5,635 Biotricity, Inc. Common Stock shares in Q2 2022, an estimated $77K.
  • Beacon Pointe Advisors first reported a position in Biotricity, Inc. Common Stock in Q1 2022 and held it in 1 quarter.
  • Beacon Pointe Advisors's Biotricity, Inc. Common Stock position peaked at $77K in Q1 2022.
  • 27 funds tracked by Wall St. Rank held Biotricity, Inc. Common Stock as of Q2 2022.

Based on Beacon Pointe Advisors's 13F filing for Q2 2022, filed 11 Aug 2022.